About Aerpio.

The company behind the science.

Joseph H. Gardner - CEO

Joseph GardenerDr. Gardner co-founded Akebia in 2007, and worked very closely with the Board of Directors and other investors to raise $50 million in very complicated economic times. Akebia successfully developed AKB-6548 for anemia, and prepared the way for spinning out the exciting programs at Aerpio. Prior to Akebia, Dr. Gardner had a widely ranging career of 23 years in pharmaceutical discovery and development at Procter & Gamble Pharmaceuticals (P&G), where all of the programs at Akebia and Aerpio had their start. Dr. Gardner contributed to the writing, coordination and review of 20 IND filings on new drug candidates at P&G. He also spent 2 years in P&G's Health Care merger and acquisition group and spent 10 years managing discovery licensing. Prior to leaving P&G, Dr. Gardner was director of the intellectual property management function which managed the entire patent portfolio for the P&G pharmaceutical business. Dr. Gardner received his B.S. with honors in Biological Chemistry from Tulane University in 1977, earned his M.S. in Chemistry (1980) from Utah State University and Ph.D. (1983) in Medicinal Chemistry from University of Wisconsin.

LinkedIn Connect with Joseph